Andreas Pahl
Chief Executive Officer en HEIDELBERG PHARMA AG .
Perfil
Andreas Pahl occupies the position of Chief Executive Officer at Heidelberg Pharma AG and Managing Director at Heidelberg Pharma Research GmbH (a subsidiary of Heidelberg Pharma AG).
In the past he occupied the position of Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd.
and Head-Late Pharmacology at Nycomed GmbH (a subsidiary of Takeda Pharmaceutical Co., Ltd.), Chief Scientific Officer of Heidelberg Pharma AG, Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg and Professor at Technical University of Berlin.
He received an undergraduate degree from Humboldt-Universität zu Berlin.
Cargos activos de Andreas Pahl
Empresas | Cargo | Inicio |
---|---|---|
HEIDELBERG PHARMA AG | Chief Executive Officer | 01/02/2024 |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German biotechnology research company. The private company is based in Ladenburg, Germany. The company was founded in 2011. Jan Schmidt-Brand has been the CEO of the company since 2004. | Chief Executive Officer | 01/02/2024 |
Antiguos cargos conocidos de Andreas Pahl.
Empresas | Cargo | Fin |
---|---|---|
Nycomed GmbH | Corporate Officer/Principal | - |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Director/Board Member | - |
Friedrich-Alexander University of Erlangen-Nuremberg | Corporate Officer/Principal | - |
Technical University of Berlin | Corporate Officer/Principal | - |
Formación de Andreas Pahl.
Humboldt-Universität zu Berlin | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
HEIDELBERG PHARMA AG | Health Technology |
Empresas privadas | 4 |
---|---|
Nycomed GmbH | |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German biotechnology research company. The private company is based in Ladenburg, Germany. The company was founded in 2011. Jan Schmidt-Brand has been the CEO of the company since 2004. | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Health Technology |
Heidelberg Pharma AG /Old/
Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |